Weekly Research Conference presents Dr. Lynn Megeney

February 5, 2018 - 12:00 p.m. to 1:00 p.m.
Speaker 
Lynn Megeney, PhD

Dr. Lynn Megeney

Senior Scientist, Regenerative Medicine Program

Ottawa Hospital Research Institute

Moderating caspase 3 activity is the key step in determining beneficial vs adverse cardiac hypertrophy

Research

Share This